40 results
8-K
EX-10.1
GALT
Galectin Therapeutics Inc.
1 Aug 24
Galectin Therapeutics Appoints Khurram Jamil, M.D. to Chief Medical Officer
7:50am
in possession of selective or specialized skills, learning, or abilities or customer contacts or customer information who has obtained such skills … and each customer or potential customer of the Company: (i) with whom or which Executive dealt on behalf of the Company; (ii) whose dealings
8-K
EX-10.1
GALT
Galectin Therapeutics Inc.
2 Sep 20
Galectin Therapeutics Appoints Joel Lewis as Chief Executive Officer
7:51am
in possession of selective or specialized skills, learning, or abilities or customer contacts or customer information who has obtained such skills … and each customer or potential customer of the Company: (i) with whom or which Executive dealt on behalf of the Company; (ii) whose dealings
8-K
EX-10.4
GALT
Galectin Therapeutics Inc.
2 Sep 20
Galectin Therapeutics Appoints Joel Lewis as Chief Executive Officer
7:51am
recruit, solicit or otherwise induce or influence any lessor, supplier, customer, agent, representative or any other person that has a business
8-K
EX-10.1
GALT
Galectin Therapeutics Inc.
20 Feb 20
Galectin Therapeutics Appoints Seasoned Biopharmaceutical Executive
7:55am
or customer contacts or customer information who has obtained such skills, learning, abilities, contacts, or information by reason of having worked … for the Company. (e) “Material Contact” shall mean the contact between Executive and each customer or potential customer of the Company: (i) with whom or which
FWP
9f82vnp
10 May 19
Free writing prospectus
8:02am
8-K
EX-99.1
dvr0tzyr
10 May 19
Other Events
7:59am
S-8
EX-99.1
iol0v0vg i80yy
26 Jun 18
Registration of securities for employees
4:17pm
8-K
EX-10.1
kp7genx7qp1fri41s53
12 Dec 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
nxd8qx9f
25 Oct 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
btnd1bkdyyy63v67
21 Sep 12
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
q27 8s0dgyzdfzs37x
25 Jul 12
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
q7z7k 81co
1 May 12
Galectin Therapeutics Announces Long-term Engagement of Dr. Scott Friedman to Advise on Liver Fibrosis Programs
12:00am
8-K
EX-10.1
k6hna
5 Mar 12
Appoints Thomas A. Mcgauley As Acting Chief Financial Officer and Extends Term of Employment of Maureen E. Foley As Chief Operating Officer
12:00am
8-K
EX-10.2
4m7p42
20 Dec 11
Other Events
12:00am
8-K
EX-10.1
clbz2
2 Jun 11
Judge Paul Pressler Elected to the Board of Directors
12:00am